Incepta Pharmaceutical has launched ‘Linatab E’ (Generic: Linagliptin+ Empagliflozin), new diabetes controlling medicine. It combines the two most remarkable and safe therapeutic classes of modern times for controlling diabetes.
It has no chance of sudden glucose fall. It is an affordable medicine where its price has been set at Linatab E 5/10 tablet at Tk30 and Linatab E 5/25 tablet at Tk40 only.
For this medicine, patients need to take only one tablet instead of the two that patients usually take.
Sources for more details:
